QQ客服 官方微博 反馈留言

浏览/检索结果: 共3条，第1-3条 帮助 已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择发表日期升序发表日期降序作者升序作者降序提交时间升序提交时间降序题名升序题名降序 Final results of the large-scale multinational trial PROFILE 1005: efficacy and safety of crizotinib in previously treated patients with advanced/metastatic ALK-positive non-small-cell lung cancer 期刊论文 2017, 卷号: 2, 期号: 3, 页码: e000219 作者:  Blackhall Fiona;  Ross Camidge D;  Shaw Alice T;  Soria Jean-Charles;  Solomon Benjamin J 收藏  |  浏览/下载：2/0  |  提交时间：2020/01/03 Alk  clinical trial  crizotinib  profile 1005   Visual effects in anaplastic lymphoma kinase (ALK)-positive advanced non-small cell lung cancer (NSCLC) patients treated with crizotinib. 期刊论文 2012, 卷号: 30, 期号: 15 作者:  Salgia, Ravi;  Solomon, Benjamin J.;  Shaw, Alice Tsang;  Camidge, D. Ross;  Evans, Tracey L. 收藏  |  浏览/下载：2/0  |  提交时间：2020/01/13 Visual effects in anaplastic lymphoma kinase (ALK)-positive advanced non-small cell lung cancer (NSCLC) patients treated with crizotinib. 会议论文 JOURNAL OF CLINICAL ONCOLOGY, 2012-05-20 作者:  Salgia, Ravi;  Solomon, Benjamin J.;  Shaw, Alice Tsang;  Camidge, D. Ross;  Evans, Tracey L. 收藏  |  浏览/下载：1/0  |  提交时间：2020/01/13